Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor

Adriana S Beltran1, Ashley G Rivenbark, Bryan T Richardson

  • 1Department of Pharmacology, The University of North Carolina at Chapel Hill, 120 Mason Farm Road, Chapel Hill, NC 27599, USA.

Breast Cancer Research : BCR
|September 29, 2011
PubMed
Abstract

Insights

Tumor-initiating cells (TICs) were generated by introducing OCT4 into normal breast cells. These cells formed aggressive breast tumors in mice, offering a new model for claudin-low breast cancer research.

Area of Science:

  • Cell Biology
  • Cancer Research
  • Stem Cell Biology

Background:

  • Tumor-initiating cells (TICs) are crucial for tumor development, maintenance, and treatment resistance.
  • Identifying and characterizing TICs is challenging due to their scarcity and poorly understood molecular signatures.
  • Ectopic expression of OCT4 offers a novel approach to generating TIC-like cells.

Purpose of the Study:

  • To generate and characterize tumor-initiating cell (TIC)-like cell lines from primary breast cells.
  • To investigate the role of OCT4 in establishing TIC-like properties and tumorigenesis.
  • To establish a patient-specific model for studying claudin-low breast cancer.

Main Methods:

  • Overexpression of OCT4 cDNA in primary human mammary epithelial cells (HMECs).
  • Culturing OCT4-transduced breast cells (OTBCs) under self-renewal conditions.
  • Assessing tumorigenic potential via injection into nude mice and gene expression analysis (microarrays).

Main Results:

  • OTBCs exhibited characteristics of cellular immortality, including overcoming senescence and overexpressing telomerase.
  • In vivo studies demonstrated that OTBCs formed poorly differentiated, high-grade breast carcinomas with colonization capabilities.
  • Gene expression profiling revealed a signature enriched in the claudin-low breast cancer subtype, with OCT4 and its downstream targets (NANOG, ZIC1) crucial for self-renewal.

Conclusions:

  • Ectopic OCT4 expression in normal breast cells generates cell lines with tumor-initiating and colonization abilities.
  • These generated cells mimic key aspects of TICs, including the development of aggressive, poorly differentiated tumors.
  • The developed OTBC model provides a valuable platform for discovering therapeutic targets in claudin-low breast cancers.

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...